Dow Down 1.40% Nasdaq Down 1.59%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.24 0.08(6.06%) Oct 1, 4:00PM EDT
Prev Close:1.32
Open:1.33
Bid:1.22 x 1000
Ask:1.26 x 1000
1y Target Est:4.05
Beta:0.64
Next Earnings Date:N/A
Day's Range:1.22 - 1.34
52wk Range:1.11 - 2.63
Volume:1,065,159
Avg Vol (3m):580,562
Market Cap:186.20M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 6.06%186.20M
LLY69.75B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):71.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback